PACAP effects were deeply investigated in NDDs, such as Parkinson’s disease and Alzheimer’s disease (Rat et al., 2011; Han et al., 2014; Maasz et al., 2017), as well as MNDs. This evidence concerns the gene ADCYAP1 and early-onset autosomal dominant Alzheimer disease.